Project Grant R01DA060923
Award Date
9/15/24
Completion Date
7/31/29
Dollars Obligated
$562K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
La Jolla, CA 92093, USA
Similar Awards
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund research to investigate the role of cholinergic interneurons in the ventral tegmental area on opioid-related behaviors. The $373,181 grant, awarded on July 15, 2024 with a completion date of June 30, 2027, aims to determine whether mu-opioid receptors on cholinergic interneurons contribute to opioid reward, consumption, and withdrawal, and how...
This $284,040 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to conduct integrated single-cell and spatial mapping of the habenula circuitry to identify projection-specific molecular pathways associated with opioid exposure. The Lieber Institute for Brain Development in Baltimore, MD will lead this research effort from September 1, 2024 to August 31, 2026. The project will generate a...
This $267,310 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research to investigate the role of parabrachial CGRP neurons in opioid reinforcement and withdrawal. The objective is to assess the functional role of these neurons in opioid-related behaviors and determine the associated gene expression and epigenetic changes. Researchers will use molecular and pharmacological approaches, including an...
This federal Project Grant award of $601,612 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support research to examine the role of the habenula-interpeduncular nucleus (IPN) circuit in the development of opioid tolerance and withdrawal. Using viral approaches, ribosome purification, and next-generation sequencing, the project aims to profile gene expression changes and neuronal calcium dynamics in the IPN in response to...
This Project Grant award for $715,238 was provided by the National Institute on Drug Abuse (NIDA), which falls under the broader Drug Use and Addiction Research Programs (CFDA 93.279). The award will fund a multi-year research effort at the University of California, San Diego (UCSD) to conduct a large-scale genome-wide association study (GWAS) of opioid-related traits in a diverse population of 500,000 individuals. The goal is to improve understanding of the genetic factors that influence...
This $519,501 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support research into the role of lateral hypothalamus (LHA) neurons and downstream dopamine signaling in motivation for opioid rewards. The project aims to determine the causal behavioral function of LHA neuron subpopulations and characterize their signaling dynamics during the development and expression of motivation for opioids. The...
This $2,223,769 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under CFDA 93.279 - Drug Use and Addiction Research Programs aims to uncover the intersection between HIV infection and opioid use in driving neuroinflammation and neurotoxicity. The University of California, San Diego (UCSD) will lead a comprehensive research effort using archived and fresh human brain tissue specimens to: Determine the relationship between HIV activity, opioid exposure, and inflammasome...
This Project Grant award for $1,073,250 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund a research study to investigate age-related differences in the effects of opioid drugs and the propensity for opioid self-administration in middle-aged rats compared to younger adult rats. The study aims to explicate the factors influencing vulnerability and resilience to opioid use disorders in the middle-aged population, which has...
This $2,902,673 project grant, awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to establish OPRM1 exon 7-associated variants as novel therapeutic targets for mitigating adverse effects of clinically used mu opioids without altering analgesia in pain management. The funded research will characterize antisense oligonucleotides (ASOs) and rabbit monoclonal antibodies (RabMABs) targeting mouse OPRM1 exon 7 variants, and...
This $265,302 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports research to investigate the neural mechanisms underlying opioid use disorder (OUD) and relapse risk during abstinence. The funded project will map the functional and anatomical pathways between the anterior and posterior paraventricular nucleus of the thalamus (PVT) and the nucleus accumbens (NAc), which have been implicated in the...